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Wednesday, February 29, 2012 613aactivated by N-methyl-d-aspartate. Due to their high Ca2þ permeability and
voltage-dependent channel block by Mg2þ, NMDA receptors play a central
role in development through stabilization of synaptic connections, as well as
in learning and memory by mediating many forms of synaptic plasticity.
The mechanisms by which the ion channel of NMDA receptors selects Ca2þ
for permeation over all other physiological ions, while binding Mg2þ and
restricting its permeation, are not well understood. We hypothesize that the
slightly different radii and electronic properties of Mg2þ and Ca2þ ions result
in drastically different free energy barriers for transition of the ions from
a binding site in the selectivity filter toward the intracellular solution. We
are applying quantitative theoretical ‘‘bottom up’’ approaches to this complex
system by combining methods of computational chemistry, molecular mechan-
ics (MM), and bioinformatics. The structure of the NMDA receptor channel is
constructed and refined using experimental information, homology modeling
and extensive molecular dynamics simulations. We are performing quantum
chemical calculations to determine the energy of the transition state of model
ligand exchange reactions that mimic divalent ion transition from the selectiv-
ity filter of NMDA receptors to water. Quantum calculations are used to
parameterize a polarizable molecular mechanics force field for these divalent
ion interactions with organic ligands with the further goal to perform MM sim-
ulations. Umbrella sampling and thermodynamic integration simulations are
used to compute free energies of transfer of divalent ions between water
and a model of the NMDA ion selectivity filter as well as free energy barriers
for these transitions.
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An Ionic Switch in the Ligand-Binding Domain of Non-NMDA Receptors
Ranjit Vijayan, Philip C. Biggin.
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The ionotropic glutamate receptors (iGluRs), activated by the amino acid
L-glutamate, account for the vast majority of excitatory neurotransmission in
the central nervous system. Given their centrality to the nervous system, it is
not surprising that these receptors have been linked to various neurological
disorders including epilepsy, Alzheimer’s and Parkinson’s disease. Based on
their sequence, pharmacological properties and function, iGluRs are classified
primarily into three subtypes, namely amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA), kainate (KA), and N-methyl-D-aspartate
(NMDA) receptors.
Previously we have reported the identification of a potential ionic switch, or
latch, located within the hinge region of non-NMDA receptors. Here we de-
scribe extensive molecular dynamics simulations to explore the conformational
behaviour of the ionic switch and its influence on the closure or opening of the
ligand-binding domain. The position of the switch appears to directly control
the conformation of the ligand-binding domain. We discuss the results with re-
spect to the general mechanism of how different ligands are able to induce the
same mechanism of domain closure.
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Kainate-type ionotropic glutamate receptors (KARs) assemble primarily as
heteromeric complexes at glutamatergic synapses. In most cases, KAR-
mediated synaptic events exhibit slow and variable deactivation kinetics in
contrast to the fast gating properties typically observed with recombinant
KARs. It is still not clear which factors contribute to the slowing of KAR re-
sponses at synapses, and it remains to be understood the low affinity neuro-
transmitter, L-Glu, triggers prolonged activations of KARs. Here, we
investigated the biophysical and stoichiometric properties of recombinant het-
eromeric KARs assembled from the GluK2 and GluK5 receptor subunits. To
do this, we used a combination of outside-out patch electrophysiology to ex-
amine functionality and a fluorescent subunit counting technique to assess het-
eromerization. As expected, the degree of heteromerization with GluK2/
GluK5 subunits in individual patch recordings showed a positive correlation
with slow deactivation kinetics and responsiveness to the agonist, AMPA. In-
terestingly, preliminary data from subunit counting experiments suggest that
the stoichiometry of heteromeric KARs is fixed. Furthermore, electrophysio-
logical experiments reveal that GluK2/GluK5 heteromers are insensitive to
external anions and cations. Since both anion and cation binding sites line
the interface between KARs subunits, our data suggest that the process ofheteromer assembly affects functionality by disrupting this region of the
mature protein.Platform: Cardiac Muscle
3116-Plat
MYH7-Mutation Associated Allelic Imbalance in Familial Hypertrophic
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Familial Hypertrophic Cardiomyopathy (FHC) is an autosomal dominant
disease of the heart. The severity of the disease ranges from mild cases to
sudden cardiac death or progression to heart failure. FHC is mostly caused
by mutations in genes encoding for sarcomeric proteins, 30-40% of the patients
are affected by missense mutations in one allele of the b-myosin heavy chain
(MYH7).
To gain further insights into the mechanisms of FHC-progression in heterozy-
gous patients we performed a comparative expression analysis of the wildtype
and the mutated MYH7 allele. We have analyzed samples from Musculus
soleus and myocardium of genotyped and clinically well-characterized
FHC-patients with different MYH7-mutations. We demonstrated an unequal
allelic mRNA expression for each mutation analysed. The ratios of the mu-
tated mRNA ranged from 29% to 66% in a mutation-specific manner. They
were comparable in myocardium and soleus muscle and, importantly, were es-
sentially the same at the protein level. Intriguingly, we observed a correlation
between life expectancy and fraction of mutated mRNA or protein. Thus, the
allelic imbalance may provide a novel factor underlying the progression of
FHC.
Our results suggest that the allelic imbalance is induced by differential regula-
tion of the mutated MYH7 mRNA-expression. Thus we aimed to identify
molecular mechanisms that may account for the mutation-related different
mRNA levels. Bioinformatical analysis revealed that mutation V606M disrupts
an exonic splicing enhancer site. Additionally, for the mutation R723G severe
changes in the mRNA secondary structure were predicted. Alternative splicing
variants of the V606-allele and a structure-related increased stability of
the R723G-allele thus may provide potential factors inducing altered levels
of mutated MYH7-mRNA.
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Hypertrophic cardiomyopathies (HCM) and dilated cardiomyopathies (DCM)
are common inherited cardiovascular diseases, often resulting from single
point mutations in genes encoding sarcomeric proteins. Genetic and clinical
studies have identified several hundred mutations, including severe disease
causing mutations in b-myosin heavy chain (MHC). Despite the clinical sig-
nificance, few single molecule studies exist for mutated b-cardiac myosin,
primarily due to difficulties of heterologous protein expression and instrumen-
tal limitations. Previous studies have used mouse a-cardiac myosin or biopsies
from patients. Those studies are not optimal to understand the molecular
mechanism of HCM/DCM because there are significant differences between
mouse a- and human b-MHC. Furthermore, biopsy samples from patients
are often inhomogeneous mixtures of wildtype (wt) and mutants. This may
explain why there have been many inconsistencies between the previous
studies.
Here, we demonstrate the first single molecule studies of recombinant human
cardiac myosin. We expressed homogenous and fully functional wt human
cardiac a- and b-S1 with human light chains bound. Then, we characterized
614a Wednesday, February 29, 2012the actin-myosin interaction using in vitro motility and laser beam trapping
assays. From the in vitro motility assay, we measured the maximum velocity
from wt a- and b-S1. Using the laser trap, we measured stroke sizes, ATP
binding rates (low [ATP]) and ADP release rates (high [ATP]). Furthermore,
we expressed several HCM (R403Q, S453C) and DCM (S532P) causing mu-
tants, and obtained preliminary in vitro motility and trap data. We have built
a modern version optical trap that can resolve the ~10 nm stroke size and ~10
ms strongly bound state of cardiac b-S1 at high [ATP]. We have further im-
proved the resolution by implementing real-time feedback control in the sys-
tem to accurately determine fine changes caused by the single mutations.
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The current study aimed at investigating the isometric tension, stiffness and
elementary steps of the cross-bridge (XBr) cycle in skinned papillary muscle
fibers from transgenic mice expressing familial hypertrophic cardiomyopathy
(FHC) associated mutation N47K. This mutation, located at the Ca2þ binding
site of myosin regulatory light chain (RLC), is associated with a rapidly pro-
gressing late onset of the disease with mid-ventricular and papillary muscle hy-
pertrophy. We studied the effect of the N47K mutation on the stiffness and the
kinetic constants using skinned muscle strips subjected to increasing concentra-
tions of MgATP, phosphate (Pi), and Ca2þ at 200 mM ionic strength, pH 7.0,
and 20C. The kinetic constants of the XBr cycle and their distribution over 6
states were deduced from the sinusoidal analysis. We found that active tension
was higher in N47K fibers compared with WT. No mutation-mediated signifi-
cant changes were observed in the Ca2þ sensitivity (pCa50) or cooperativity
(nH). The apparent rate constants 2pb and 2pc were smaller in N47K fibers
compared with WT. The rate constant of XBr detachment step (k2) was smaller
while the equilibrium constant of force generation (K4) was larger in N47K
fibers. The stiffness of the standard activation and the number of the strongly
attached XBr were larger in N47K than in WT.These results suggest that the
higher tension in N47K fibers may be related to a larger number of strongly
attached XBr. We conclude that the N47K mutation may initiate a hypertrophic
response through changes in myosin XBr kinetics leading to increased
force during the systole, which eventually results in a pathologic phenotype
in patients carrying this FHC-linked RLC mutation. Supported by NIH-
HL070041 (MK), NIH-HL071778 and HL090786 (DSC) and AHA
10POST3420009 (PM).
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Distribution of orientations of myosin was examined in ex-vivo myofibrils
from hearts of transgenic (Tg) mice expressing Familial Hypertrophic Car-
diomyopathy (FHC) troponin T (TnT) mutations I79N, F110I and R278C.
Humans are heterozygous for sarcomeric FHC mutations and so hypertro-
phic myocardium contains a mixture of the wild-type (WT) and mutated
(MUT) TnT. If mutations are expressed at a low level there may not be a sig-
nificant change in the global properties of heart muscle. In contrast, mea-
surements from a few molecules avoid averaging inherent in the global
measurements. It is thus important to examine the properties of only
a few molecules of muscle. To this end, the lever arm of one out of every
60,000 myosin molecules was labeled with a fluorescent dye and a small
volume within the A-band (~ 1 fL) was observed by confocal microscopy.
This volume contained on average 5 fluorescent myosin molecules. The le-
ver arm assumes different orientations reflecting different stages of acto-
myosin enzymatic cycle. We measured the distribution of these orientations
by recording polarization of fluorescent light emitted by myosin-bound fluo-
rophore during rigor and contraction. The distribution of orientations of rigor
WT and MUT myofibrils was significantly different. There was a large dif-
ference in the width and of skewness and kurtosis of rigor distributions.
These findings suggest that the hypertrophic phenotype associated with the
TnT mutations can be characterized by a significant increase in disorder
of rigor cross-bridges.3120-Plat
Mutations in thin Filament Proteins that Cause Familial Dilated Cardio-
myopathy Uncouple Troponin I Phosphorylation from Changes in Myofi-
brillar Ca2D-Sensitivity
Massimiliano Memo, Andrew E. Messer, Man Ching Leung,
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To investigate the molecular mechanism leading to familial dilated cardiomy-
opathy we studied 7 different DCM-causing mutations in thin filament pro-
teins by in vitro motility assay. Troponin I K36Q and troponin C G159D
mutant troponin was extracted from explanted human hearts. Troponin T
DK210 and R141W mutant troponin, and actin E361G were extracted from
transgenic mouse heart. Mutant a-tropomyosin E40K and E54K was ex-
pressed in baculovirus/sf9 cells. We reconstituted thin filaments in vitro
with the mutant sample of interest, or its correspondent wild-type, combined
with troponin or a-tropomyosin from human donor tissue. We could not ob-
serve any common pattern for the absolute Ca2þ-sensitivity of the mutants
compared with the WT thin filaments. In contrast to this we consistently ob-
served that DCM mutations affect the relationship between Ca2þ-sensitivity
and troponin I phosphorylation by PKA. Normally, PKA phosphorylation
of troponin I causes a 2-3 fold decrease in myofibrillar Ca2þ-sensitivity but
we found that, in thin filaments containing DCM mutations, Ca2þ-sensitivity
did not change with the level of troponin I phosphorylation. Uncoupling of
Ca2þ-sensitivity from troponin I phosphorylation was observed for all
DCM mutations tested irrespective of the gene mutated or the source of
the mutant protein. We tested the DCM mutation dose-dependency by mixing
a-tropomyosin E40K, with the wild-type in different ratios, assembling it into
thin filaments and comparing Ca2þ-sensitivity when troponin I was phosphor-
ylated and dephosphorylated. The result was a dramatic effect of uncoupling
with small ratios of the mutant protein with complete uncoupling at 50% mu-
tant. We conclude that the causative property shared by mutations in contrac-
tile proteins that cause DCM is a blunted response to changes in troponin I
phosphorylation that could impair the normal response to adrenergic
stimulation.
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Length-Dependent Prolongation of Relaxation in Rabbit Right Ventricular
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The phosphorylation state of several cardiac myofilament proteins changes
with the level of stretch in twitch-contracting cardiac muscles. It remains un-
clear which kinases are involved in the length-dependent phosphorylation of
these proteins. Therefore, we set out to investigate which kinases are involved
after a step-wise change in cardiac muscle length. We hypothesize that myofil-
ament protein phosphorylation by PKCbII and PKA alter contractile kinetics
during length-dependent activation. Right ventricular intact trabeculae were
isolated from New Zealand White rabbit hearts and stimulated to contract at
1 Hz. Twitch force recordings where taken before and after administration of
kinase inhibitors at varying muscle lengths at 37C. PKCbII inhibition signif-
icantly decreased time from stimulation to peak force (TTP), time from peak
force to 50% relaxation (RT50), and time from peak force to 90% relaxation
(RT90) at optimal muscle length. However, developed tension did not signifi-
cantly change at either muscle length studied. Non-specific PKA inhibition sig-
nificantly decreased TTP and RT50 at both taut and optimal muscle lengths.
Detection of Ser/Thr phosphorylation with ProQ-diamond staining indicates
a role for PKCbII in the phosphorylation of tropomyosin and myosin light
chain-2 (MLC2) and PKA for tropomyosin, troponin-I, and MLC2. Our data
provide evidence for two signaling kinases which act upon myofilament pro-
teins during length-dependent activation, and provide further insight for
length-dependent myofilament function.
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Age-associated diastolic heart failure occurs when the amount of blood filling
the heart between beats is reduced due to slow relaxation and increased pas-
sive stiffness of the left ventricle. We are testing the hypothesis that slowed
active relaxation in diastolic heart failure is caused in part by age-dependent
